PHARMACOKINETICS OF INTERMITTENTLY ADMINISTERED INTRAVENOUS FOSCARNET IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS WITH SERIOUS CYTOMEGALO-VIRUS RETINITIS

被引：58
作者：
AWEEKA, F
GAMBERTOGLIO, J
MILLS, J
JACOBSON, MA
机构：
[1] UNIV CALIF SAN FRANCISCO,DIV CLIN PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[3] SAN FRANCISCO GEN HOSP,MED SERV,SAN FRANCISCO,CA 94110
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1989年 / 33卷 / 05期
关键词：
D O I：
10.1128/AAC.33.5.742
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：742 / 745
页数：4
相关论文
共 14 条
[1]  
CACOUB P, 1988, CLIN NEPHROL, V29, P315
[2]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[3]   TREATMENT OF CYTOMEGALOVIRUS PNEUMONITIS WITH FOSCARNET (TRISODIUM PHOSPHONOFORMATE) IN PATIENTS WITH AIDS [J].
FARTHING, C ;
ANDERSON, MG ;
ELLIS, ME ;
GAZZARD, BG ;
CHANAS, AC .
JOURNAL OF MEDICAL VIROLOGY, 1987, 22 (02) :157-162
[4]  
GAUB J, 1987, AIDS, V1, P27
[5]  
Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17
[6]   FOSCARNET TREATMENT OF CYTOMEGALO-VIRUS RETINITIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
JACOBSON, MA ;
ODONNELL, JJ ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :736-741
[7]  
JACOBSON MA, 1988, J INFECT DIS, V158, P862, DOI 10.1093/infdis/158.4.859
[8]   INTRAVENOUS FOSCARNET FOR THE TREATMENT OF SEVERE CYTOMEGALO-VIRUS INFECTION IN ALLOGRAFT RECIPIENTS [J].
KLINTMALM, G ;
LONNQVIST, B ;
OBERG, B ;
GAHRTON, G ;
LERNESTEDT, JO ;
LUNDGREN, G ;
RINGDEN, O ;
ROBERT, KH ;
WAHREN, B ;
GROTH, CG .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1985, 17 (02) :157-163
[9]  
OBERG B, 1983, PHARMACOL THERAPEUT, V19, P387
[10]   PHARMACOKINETICS, SAFETY AND PRELIMINARY CLINICAL-EXPERIENCES USING FOSCARNET IN THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN BONE-MARROW AND RENAL-TRANSPLANT RECIPIENTS [J].
RINGDEN, O ;
LONNQVIST, B ;
PAULIN, T ;
AHLMEN, J ;
KLINTMALM, G ;
WAHREN, B ;
LERNESTEDT, JO .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :373-387
12